相关实验视频

Updated: Sep 11, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

一个辅助剂数据库用于疫苗和免疫治疗药物的临床前评估

Yayoi Natsume-Kitatani¹, Kouji Kobiyama², Yoshinobu Igarashi³

¹Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka 566-0002, Japan; Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Tokushima 770-8503, Japan; Institute for Protein Research, the University of Osaka, Suita, Osaka 565-0871, Japan.

Cell chemical biology

|August 12, 2025

概括

一个新的辅助剂数据库 (ADB) 整合了转录组数据,以改善疫苗辅助剂查. 这种数据驱动的方法增强了对新型辅助剂候选者的疗效和安全性评估.

科学领域:

免疫学免疫学免疫学
毒理学毒理学毒理学
生物信息学是一种生物信息学.

背景情况:

辅助剂对于提高疫苗对传染病的疗效至关重要.
目前评估辅助剂有效性和安全性的方法有限,限制了大规模查.
转录组数据为了解辅助机制和潜在毒性提供了强大的工具.

研究的目的:

开发一个原型的辅助剂数据库 (ADB) 进行全面的辅助剂评估.
为了实现转录基因数据的跨数据库集成,以进行增强的分析.
建立一个数据驱动的框架,用于选助理候选人.

主要方法:

开发了一种原型辅助剂数据库 (ADB),其中包含25种辅助剂的转录组数据.
确保数据生成协议与开放的TG-GATE (OTG) 毒基因组学数据库一致.
集成的ADB和OTG数据用于交叉数据库分析和机器学习模型开发.

主要成果:

转录基因模式有效地区分了不同物种和器官的个体辅助剂.
机器学习模型使用集成数据集成功预测了辅助性和肝毒性.
通过数据驱动分析,确定了素的辅助活性和FK565的肝毒性.

结论:

辅助数据库 (ADB) 与开放的TG-GATE (OTG) 结合,为基于转录学的选提供了一个强大的框架.
这种方法促进了基于数据的辅助剂有效性和安全性的评估.
能够有效地识别和描述新型辅助剂候选者.

关键词:

在NOD1中,NOD1是NOD1.在RLRLR中,RLR是指RLR.刺痛是一种刺痛.这是一个TLR.一个辅助的辅助者.这是先天免疫力.机器学习是机器学习.药理学药理学药理学药理学药理学毒理学毒理学毒理学疫苗疫苗疫苗疫苗

更多相关视频

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

相关概念视频

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...